首页
登录
职称英语
The evidence has gotten much stronger that a substance known as C-reactive p
The evidence has gotten much stronger that a substance known as C-reactive p
游客
2023-08-21
57
管理
问题
The evidence has gotten much stronger that a substance known as C-reactive protein may be every bit as important as cholesterol(胆固醇)in the diagnosis and treatment of heart disease. Back in 2002, a thought-provoking study found that a blood test for C-reactive protein, called CRP, was actually better than the standard cholesterol test at predicting the risk of a heart attack or a stroke. Now two studies published in The New England Journal of Medicine have shown that drugs that reduce the levels of that protein in patients with severe heart disease can slow the progression of atherosclerosis(动脉硬化症)and prevent heart attacks and cardiac-related deaths.
Although the studies came laced with caveats, their cumulative impact suggests that cardiology is in the midst of a revolutionary shift in understanding the causes of heart disease. After years of focusing on the role of cholesterol in clogging arteries, researchers now recognize C-reactive protein, a measure of inflammation(炎症)in artery walls and elsewhere, as a prime risk factor in its own right.
The key study published last week found that heart disease patients who were given high doses of a cholesterol—lowering statin drug also experienced a drop in CRP levels and in heart attacks. Thus the high dose statin packed a double wallop.
These findings apply only to patients already suffering from severe heart disease. A separate clinical trial will seek to determine whether lowering C-reactive protein can reduce heart attacks in healthy patients with normal cholesterol levels but above-average levels of C-reactive protein. Nearly half of all people who suffer heart attacks have normal cholesterol levels, so it is critical to devise tests and treatments to reduce their risk.
Even before the final clinical results are in, it would seem prudent for all overweight couch potatoes who think they are safe because their cholesterol levels are low to get their C-reactive protein levels tested. If their CRP levels are high, they may be spurred to lose weight, exercise and stop smoking to bring down those protein levels. High doses of statins, with their risk of side effects, would presumably be a last resort. [br] The author tells us that______.
选项
A、C-reactive protein is not as important as cholesterol
B、C-reactive protein as a cause of heart disease is still unclear to researchers
C、people had better test C-reactive protein in spite of their low cholesterol level
D、it would be safe for people whose cholesterol levels are normal
答案
C
解析
根据最后一段第一句可知,对于那些胆固醇水平低,从而自认为安全的终日懒散的肥胖者来说,去做一个C-反应蛋白质测试不失为明智之举。由此可知,C)“尽管胆固醇水平低,人们最好还是测试一下C-反应蛋白质”正确。
转载请注明原文地址:http://tihaiku.com/zcyy/2943502.html
相关试题推荐
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
Itishardlynecessaryformetocitealltheevidenceofthedepressingsta
Abouttwoweeksago,theU.S.DepartmentofHealth’sSubstanceAbuseandMe
Abouttwoweeksago,theU.S.DepartmentofHealth’sSubstanceAbuseandMe
随机试题
Thecurseofjetlaghasstruckmostinternationaltravelersatonetimeor
What’syourearliestchildhoodmemory?Canyourememberlearningtowalk?Or
Wildclaimsonlabelsofworthlessmedicinesaremuchlessfrequentthanthe
简述薪酬管理体系的公平性要求。
栈桥两侧和栈桥码头四周应设置高度不低于()的防护栏杆。防护栏杆上杆任何部位
证券A的标准离差率为40%,β系数为0.5,证券B的标准离差率为20%,β系数为
已经被批准用于绝经后女性OP防治的选择性雌激素调节因子类药物为A.屈洛昔芬 B
下列细胞不具有抗原递呈作用的是:()A.巨噬细胞 B.上皮细胞 C.
患者胃肠热盛,大便秘结腹满硬痛而拒按,潮热,神昏谵语,但又兼见面色苍白,四肢厥冷
为保障建设工程项目圆满实现专业化管理目标,委托人和项目管理企业在签约和履约阶段均
最新回复
(
0
)